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Intratumour heterogeneity in the uptake of blood-borne technetium-labelled human serum albumin (
99mTc-HSA) was studied in
human melanoma xenografts in an attempt to identify transport barriers leading to inadequate and heterogeneous uptake of
macromolecular therapeutic agents in tumours. The Bioscope imaging system, which can detect the distribution of
99mTc in 10-mm-
thick tissue sections with a spatial resolution of just above 50mm, was used to image the
99mTc-HSA uptake. Xenografted tumours of
four human melanoma cell lines were included in the study. Significant intratumour heterogeneity in the uptake of
99mTc-HSA was
detected. The heterogeneity had two distinctly different components, one random and one radial component. The uptake was
lowest in the centre of the tumours and increased towards the tumour periphery. This radial heterogeneity was superimposed by a
random heterogeneity, that is, spots with high uptake colocalised with spots with high vascular density and regions without significant
uptake colocalised with necrotic regions. The magnitude of the heterogeneity did not change significantly with time after the
administration of
99mTc-HSA. The tumours showed a random and a radial heterogeneity in blood perfusion similar to that in the
uptake of
99mTc-HSA. The observations reported here suggest that the intratumour heterogeneity in the distribution of
99mTc-HSA
was initiated primarily because of heterogeneity in the supply of
99mTc-HSA through the microvasculature, and that the presence of
severe transport barriers in the tumour interstitium prevented significant equalisation of the initial heterogeneity with time.
Consequently, strategies for improving the delivery of macromolecular therapeutic agents to tumours should focus on increasing the
tumour blood perfusion to increase the total uptake and improving the diffusion conditions in the tumour interstitium to diminish the
heterogeneity in the uptake.
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Novel strategies for the treatment of cancer involving macro-
molecular therapeutic agents such as growth factors, monoclonal
antibodies, immunomodulators, oligonucleotides, gene therapy
vectors and encapsulated drugs have been developed recently (Jain,
1998). Preclinical studies of the therapeutic usefulness of such
agents in several in vitro and in vivo cancer models have given
promising results (Yuan, 1998). However, inadequate and hetero-
geneous uptake in tumour tissue has been shown to be a major
obstacle for efficient use of macromolecules in clinical cancer
therapy (Yuan, 1998; Jain, 2001). Improved strategies are therefore
needed to increase the macromolecule delivery to tumours.
The uptake of macromolecular therapeutic agents in tumour
tissue depends on the physical and chemical properties of the macro-
molecule and the biology of the tissue. Macromolecular properties
exerting a significant influence on the uptake include molecular
weight, shape, charge and affinity for binding to stromal and
parenchymal tissues (Dellian et al, 2000). Biological factors that
may prevent adequate uptake include low microvascular density,
poor perfusion, low transvascular permeability, high interstitial
fluid pressure and a dense, well-organised extracellular matrix
(Hobbs et al, 1998). However, the mechanisms regulating the
uptake are not well understood. Novel strategies for increasing the
delivery can probably not be developed without identification of
the barriers limiting the uptake. Such identification requires care-
ful studies with well-characterised experimental tumours and macro-
molecules with well-known physical and chemical properties.
The mechanisms governing the uptake of macromolecular
therapeutic agents in human melanoma xenografts are currently
being investigated in our laboratory, using albumin as a model
molecule for macromolecular therapeutic agents (Graff et al, 2000,
2001; Bjrnæs and Rofstad, 2001). We have previously measured
the global uptake of blood-borne albumin, and found that it
was strongly correlated to the extracellular volume fraction of
the tumour tissue (Graff et al, 2000) and was not limited by
the permeability of the microvascular wall (Bjrnæs and Rofstad,
2001; Graff et al, 2001). In the present work, the intratumour
heterogeneity in the uptake of technetium-labelled human serum
albumin (
99mTc-HSA) was studied and related to the intratumour
heterogeneity in necrosis, vascular density, blood perfusion and
extracellular volume fraction. Human melanoma xenografts having
retained essential biological features of the donor patients’ tumours,
including histology, growth rate and vascularisation, have been
established and characterised in our laboratory (Rofstad, 1994).
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time-independent intratumour heterogeneity in
99mTc-HSA up-
take, caused primarily by heterogeneous supply of
99mTc-HSA
through the tumour microvasculature and poor diffusion condi-
tions for
99mTc-HSA in the tumour interstitium.
MATERIALS AND METHODS
Mice and tumours
Adult (8 12 weeks of age) female BALB/c-nu/nu mice, bred at our
research institute, were used as host animals for xenografted
tumours. The mice were maintained under specific pathogen-free
conditions at constant temperature (24 261C) and humidity
(30 50%). Sterilised food and tap water were given ad libitum.
Four human melanoma lines (A-07, D-12, R-18 and U-25),
described in detail elsewhere (Rofstad, 1994), were included in
the study. Tumours were initiated from exponentially growing
monolayer cultures verified to be free from Mycoplasma contam-
ination. The cells were cultured in RPMI-1640 medium (25mM
HEPES and L-glutamine) supplemented with 13% bovine calf
serum, 250mgl
 1 penicillin and 50mgl
 1 streptomycin. Approxi-
mately 3.5 10
5 cells in 10mlo fC a
2+- and Mg
2+-free Hanks’
balanced salt solution were inoculated intradermally into the
flanks of mice by using a 100-ml Hamilton syringe. The tumours
were deposited above the subcutaneous muscle tissue in the deeper
part of the dermis. The growth and histological appearance of the
tumours have been described elsewhere (Rofstad, 1994). D-12 and
U-25 tumours develop necrotic regions during growth, whereas
A-07 and R-18 tumours do not. Tumours with volumes within the
range of 300 600mm
3 were subjected to investigation. Tumour
volume (V) was calculated as V¼(p/6) ab
2, where a is the longer
and b is the shorter of two perpendicular diameters, measured with
callipers. Animal experiments were approved by the Institutional
Committee on Research Animal Care and were performed
according to the ethical standards of the UKCCCR ‘Guidelines
for the Welfare of Animals in Experimental Neoplasia’ (Workman
et al, 1998).
Bioscope
The Bioscope system (IDE AS, Oslo, Norway), designed to image
the distribution of isotopes in tissue sections with high spatial
resolution (Overdick et al, 1997), was used to study intratumour
heterogeneity in macromolecule uptake, extracellular volume
fraction and blood perfusion (Figure 1). The sensor of this system
is a 300-mm-thick double-sided silicon strip detector with a
sensitive area of 32 32mm. The detector has 640 strips in each
direction, that is, a strip pitch of 50mm. Four tumour sections can
be imaged simultaneously, as illustrated in Figure 1A. The posi-
tions of ionising events are registered by the detector and trans-
ferred to a computer. Low-energy b-emitters, such as
99mTc, give
images with a spatial resolution of just above 50mm. Quantitative
analysis of images was performed by using the analySIS image
processing system (Soft Imaging System GmbH, Mu ¨nster, Ger-
many). The radial distribution of activity was determined by
dividing the tumour images into five sectors and analysing each
sector separately, as illustrated in Figure 1B. The sectors were
bounded by lines drawn at distances of nR/5 from the tumour
centre, where R is the tumour radius and n is the sector number.
The skin surrounding the tumours was excluded from the analyses.
Macromolecule uptake
99mTc-HSA was diluted in 0.9% saline and administered intra-
venously to tumour-bearing mice in a bolus dose of 32mgkg
 1
(approximately 8 10
2MBqkg
 1). The mice were killed by
cervical dislocation 1, 5, 10, 30, 60, 120 or 180min after the
administration, and the tumours were frozen in liquid nitrogen
and cut into two halves. One of the halves was subjected to
measurement of activity in a gamma counter (Wallac Oy, Turku,
Finland) to ascertain that the kinetics of the global uptake was
consistent with previous measurements. Frozen sections of 10-mm
thickness were prepared from the other halves, using standard
procedures. The spatial distribution of activity in these sections,
that is, the concentration of
99mTc-HSA, was imaged with the
Bioscope system and used as a parameter for the intratumour
heterogeneity in macromolecule uptake. The sections were stained
with haematoxylin and eosin after the imaging and examined by
light microscopy.
Extracellular volume fraction
99mTc-HSA in doses similar to those described above was
administered intravenously to tumour-bearing mice with ligated
renal arteries. The procedure used for the ligation of renal arteries
has been described elsewhere (Bjrnæs et al, 2000). The mice were
killed and the tumours were frozen in liquid nitrogen 3h after the
Figure 1 (A) Schematic illustration of the Bioscope system. The sensor
of the system is a 300-mm-thick double-sided silicon strip detector with a
sensitive area of 32 32mm. The detector has 640 strips in each direction.
Four tumour slices can be imaged simultaneously. (B) Bioscope image of an
A-07 tumour. The concentration of
99mTc in the tumour tissue is
proportional to the intensity in the image. Quantitative analysis of the radial
distribution of
99mTc was performed by dividing the images into five sectors
and analysing each sector separately. The sectors were bounded by lines
drawn at distances of nR/5 from the tumour centre, where R is the tumour
radius and n is the sector number.
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British Journal of Cancer (2003) 88(2), 291–297 & 2003 Cancer Research UKadministration of
99mTc-HSA. Frozen sections (10-mm thick) were
prepared from the tumours, and the spatial distribution of activity
in the sections, that is, the concentration of
99mTc-HSA, was
imaged with the Bioscope system and used as a parameter for the
intratumour heterogeneity in extracellular volume fraction.
Blood perfusion
Na
99mTcO4 was administered intravenously to tumour-bearing
mice in a bolus dose (approximately 8 10
2MBqkg
 1). The mice
were killed and the tumours were frozen in liquid nitrogen 45s
after the administration of Na
99mTcO4. Frozen sections (10-mm
thick) were prepared from the tumours, and the spatial distribu-
tion of activity in the sections, that is, the concentration of
Na
99mTcO4, was imaged with the Bioscope system and used as a
parameter for the intratumour heterogeneity in perfusion.
Statistical analysis
Results are presented as arithmetic mean7s.e.m. The Pearson
Product Moment Correlation test was used under conditions of
normality and equal variance to determine the strength of cor-
relations between variables. The statistical analysis was performed
by using SigmaStat statistical software (Jandel Scientific GmbH,
Erkrath, Germany).
RESULTS
Qualitative studies
Qualitative examinations of Bioscope images revealed significant
intratumour heterogeneity in the uptake of
99mTc-HSA. The
heterogeneity had two distinctly different components, one
random and one nonrandom radial component. The uptake was
lowest in the centre of the tumours and increased towards the
tumour periphery. This radial heterogeneity was superimposed by
a random heterogeneity. A-07 and R-18 tumours showed spots
with high uptake and randomly distributed within the tissue. D-12
and U-25 tumours showed randomly distributed regions without
significant uptake in addition to spots with high uptake.
Bioscope images of
99mTc-HSA activity were superimposed on
histological images in an attempt to identify the causes of the
random component of the heterogeneity (Figure 2). Spots with
high uptake colocalised with spots with high vascular density,
either the tumour host was killed minutes (Figure 2A) or hours
(Figure 2B) after the administration of
99mTc-HSA. Regions with-
out significant uptake colocalised with necrotic regions indepen-
dent of the time between the administration of
99mTc-HSA and the
killing of the tumour host (Figure 2C).
Moreover, qualitative examinations of Bioscope images of
Na
99mTcO4 activity revealed an intratumour heterogeneity in
blood perfusion similar to that in the uptake of
99mTc-HSA. The
perfusion was lowest in the centre of the tumours and increased
towards the tumour periphery. Spots with high perfusion
colocalised with spots with high vascular density and regions
without perfusion co-localised with necrotic regions (data not
shown).
Quantitative studies
The Bioscope images were divided into five sectors (Figure 1B)
to quantify the radial heterogeneity in the uptake of
99mTc-HSA.
Representative data for A-07 tumours frozen 1, 30 or 180min
after the administration of
99mTc-HSA are presented in Figure 3,
illustrating three general observations: (a) the concentration of
99mTc-HSA increased with time, (b) the concentration of
99mTc-
HSA increased linearly with the distance from the tumour centre
Figure 2 (A) Left: Bioscope image of an R-18 tumour.
99mTc-HSA was
administered intravenously to the tumour-bearing mouse. The mouse was
killed and the tumour was frozen in liquid nitrogen 1min after the
administration of
99mTc-HSA. The concentration of
99mTc-HSA in the
tumour tissue is proportional to the intensity in the Bioscope image. Right:
histological image of the tumour region demarcated with red lines in the
Bioscope image. Low-pass-filtered Bioscope image, showing the concen-
tration of
99mTc-HSA in green, is superimposed on the histological image.
(B) Left: Bioscope image of an R-18 tumour.
99mTc-HSA was administered
intravenously to the tumour-bearing mouse. The mouse was killed and the
tumour was frozen in liquid nitrogen 60min after the administration of
99mTc-HSA. The concentration of
99mTc-HSA in the tumour tissue is
proportional to the intensity in the Bioscope image. Right: histological image
of the same tumour section. Low-pass-filtered Bioscope image, showing the
concentration of
99mTc-HSA in green, is superimposed on the histological
image. (C) Histological image of a D-12 tumour. Low-pass-filtered Bioscope
image, showing the concentration of
99mTc-HSA in green, is superimposed
on the histological image.
99mTc-HSA was administered intravenously to
the tumour-bearing mouse. The mouse was killed and the tumour was
frozen in liquid nitrogen 180min after the administration of
99mTc-HSA.
Necrotic regions are indicated by N.
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British Journal of Cancer (2003) 88(2), 291–297 & 2003 Cancer Research UKand (c) the ratio of the concentration of
99mTc-HSA in the tumour
periphery and the tumour centre was independent of time within
the time interval of 1 180min. Similar analysis revealed that these
three observations were also valid for R-18 tumours (data not
shown). Consequently, the magnitude of the radial heterogeneity
in the uptake of
99mTc-HSA was independent of time within the
time interval of 1 180min in both A-07 and R-18 tumours, that is,
tumours without necrotic regions. Moreover, the uptake of
99mTc-
HSA and the magnitude of the radial heterogeneity in the uptake
were independent of tumor volume within the volume range
studied here, that is, 300–600mm
3, in both A-07 and R-18 tumors
(data not shown).
Data for individual tumours were normalised and pooled to
compare the radial heterogeneity in the uptake of
99mTc-HSA in A-
07 and R-18 tumours (Figure 4). A significant difference between
the two tumour types could not be detected; the concentration of
99mTc-HSA in the tumour periphery was higher than that in the
tumour centre by a factor of approximately 1.5 in both tumour
lines (P50.05). The same procedure was used to quantify the
radial heterogeneity in the uptake of
99mTc-HSA in D-12 and U-25
tumours, that is, tumours showing significant necrotic regions
(Figure 5). The quantitative analysis did not reveal a significant
radial gradient in the uptake of
99mTc-HSA in these tumour
lines (P40.05), although the qualitative examination showed that
the uptake in non-necrotic tissue was substantially higher in the
tumour periphery than in the tumour centre. Consequently, the
data in Figure 5 most likely reflect that necrotic regions without
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Figure 3 Concentration of
99mTc-HSA vs distance from tumour centre
in three individual A-07 tumours.
99mTc-HSA was administered intra-
venously to tumour-bearing mice. The mice were killed and the tumours
were frozen in liquid nitrogen 1min (K), 30min (J) or 180min (.) after
the administration of
99mTc-HSA. Tumour size was normalised, that is,
tumour radius was assigned a value of 1.0. The concentration of
99mTc-HSA was also normalised, that is, the mean concentration of
99mTc-HSA in the section from the tumour frozen 1min after the
administration of
99mTc-HSA was assigned a value of 1.0. One section was
analysed for each tumour.
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Figure 4 Concentration of
99mTc-HSA vs distance from tumour centre
in tumours without necrotic regions (A-07 and R-18).
99mTc-HSA was
administered intravenously to tumour-bearing mice. The mice were killed
and the tumours were frozen in liquid nitrogen 1 180min after the
administration of
99mTc-HSA. Tumour size was normalised, that is, tumour
radius was assigned a value of 1.0. The concentration of
99mTc-HSA was
also normalised, that is, the mean concentration of
99mTc-HSA in each
tumour section was assigned a value of 1.0. One section was analysed for
each tumour. Points represent mean values of 11 (A-07) or 7 (R-18)
tumours. Bars represent s.e.m.
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Figure 5 Concentration of
99mTc-HSA vs distance from tumour centre
in tumours with necrotic regions (D-12 and U-25).
99mTc-HSA was
administered intravenously to tumour-bearing mice. The mice were killed
and the tumours were frozen in liquid nitrogen 1 180min after the
administration of
99mTc-HSA. Tumour size was normalised, that is, tumour
radius was assigned a value of 1.0. The concentration of
99mTc-HSA was
also normalised, that is, the mean concentration of
99mTc-HSA in each
tumour section was assigned a value of 1.0. One section was analysed for
each tumour. Points represent mean values of eight (D-12) or four (U-25)
tumours. Bars represent s.e.m.
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British Journal of Cancer (2003) 88(2), 291–297 & 2003 Cancer Research UKsignificant uptake of
99mTc-HSA had a random radial distribution
and were sufficiently large to govern the overall radial hetero-
geneity in the uptake of
99mTc-HSA.
The radial distributions in blood perfusion (Figure 6) and
extracellular volume fraction (Figure 7) were quantified in A-07
and R-18 tumours in an attempt to identify causes of the radial
heterogeneity in the uptake of
99mTc-HSA. The perfusion was
lowest in the centre of the tumours and increased towards the
tumour periphery. A-07 tumours showed approximately three-fold
higher perfusion in the periphery than in the centre (P50.05),
whereas in R-18 tumours, the perfusion in the periphery was
higher than that in the centre by a factor of approximately 1.5
(P50.05). The radial heterogeneity in extracellular volume
fraction, on the other hand, was weak in both tumour lines. The
extracellular volume fraction decreased slightly towards the
tumour periphery in A-07 tumours (P¼0.030) and increased
slightly with the distance from the tumour centre in R-18 tumours
(P¼0.035).
DISCUSSION
Intratumour heterogeneity in the uptake of
99mTc-HSA was studied
in human melanoma xenografts by utilising the unique properties
of the newly developed Bioscope imaging system (Overdick et al,
1997). This system made it feasible to image the activity of
99mTc-HSA in 10-mm-thick tumour sections at a spatial resolution
of just above 50mm. The images could be subjected to quantitative
analysis to determine the uptake of
99mTc-HSA in any freely
selected tumour subregion. Moreover, correlations between the
uptake of
99mTc-HSA and histological characteristics could be
searched for by superimposing Bioscope images on histological
images obtained from the same tumour sections.
Studies of intratumour heterogeneity in the uptake of macro-
molecules using a radiolabelled molecule as a probe require
specific precautions to avoid experimental artefacts and incorrect
interpretation of data. Degradation of the probe, resulting in
unbound and hence freely diffusible activity, may generate data
indicating that the heterogeneity is lower than the true hetero-
geneity.
99mTc-HSA was used as a model molecule for macro-
molecular therapeutic agents in the present work. Intratumour
heterogeneity in
99mTc-HSA concentration was seen within a few
minutes after the administration of the probe, and this initial
heterogeneity was maintained at unchanged magnitude through-
out the whole observation period of 180min. In contrast, control
experiments with Na
99mTcO4 showed that the initial heterogeneity
in Na
99mTcO4 concentration decayed rapidly with time, resulting
in a homogeneous distribution within less than an hour.
Consequently, degradation of
99mTc-HSA probably did not
represent a serious problem in our study.
Significant intratumour heterogeneity in the uptake of
99mTc-
HSA was detected. The heterogeneity had two distinctly diffe-
rent components, one random and one radial component. In
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Figure 6 Blood perfusion vs distance from tumour centre in A-07 and R-
18 tumours. Na
99mTcO4 was administered intravenously to tumour-
bearing mice. The mice were killed and the tumours were frozen in liquid
nitrogen 45s after the administration of Na
99mTcO4. The concentration of
Na
99mTcO4 in the tumour tissue was used as a parameter for blood
perfusion. Tumour size was normalised, that is, tumour radius was assigned
a value of 1.0. Blood perfusion was also normalised, that is, the mean
concentration of Na
99mTcO4 in each tumour section was assigned a value
of 1.0. One section was analysed for each tumour. Points represent mean
values of 8 (A-07) or 7 (R-18) tumours. Bars represent s.e.m.
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Figure 7 Extracellular volume fraction vs distance from tumour centre in
A-07 and R-18 tumours.
99mTc-HSA was administered intravenously to
tumour-bearing mice with ligated renal arteries. The mice were killed and
the tumours were frozen in liquid nitrogen 3h after the administration of
99mTc-HSA. The concentration of
99mTc-HSA in the tumour tissue was
used as a parameter for extracellular volume fraction. Tumour size was
normalised, that is, tumour radius was assigned a value of 1.0. Extracellular
volume fraction was also normalised, that is, the mean concentration of
99mTc-HSA in each tumour section was assigned a value of 1.0. One
section was analysed for each tumour. Points represent mean values of 8
(A-07) or 7 (R-18) tumours. Bars represent s.e.m.
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British Journal of Cancer (2003) 88(2), 291–297 & 2003 Cancer Research UKnon-necrotic tissue, the uptake was lowest in the centre of the
tumours and increased towards the tumour periphery. The radial
distribution of
99mTc-HSA was initiated within minutes after the
administration of
99mTc-HSA and was maintained at least until
maximum uptake was attained, approximately 180min later.
Mathematical modelling has suggested that radial heterogeneity
in the uptake of macromolecules in tumours could be because of
radial heterogeneity in blood perfusion, histopathological char-
acteristics, microvascular permeability and/or interstitial fluid
pressure (Baxter and Jain, 1988, 1990; Jain and Baxter, 1988;
Fujimori et al, 1989; Thomas et al, 1989).
The radial intratumour heterogeneity in blood perfusion and
extracellular volume fraction was determined experimentally in the
present work by using
99mTc-labelled molecules as tracers and the
Bioscope imaging system for detection. Experimental studies with
the same melanoma lines of intratumour heterogeneity in the
permeability of the microvasculature to Gd-labelled HSA and
intratumour heterogeneity in interstitial fluid pressure have been
reported previously (Bjrnæs and Rofstad, 2001; Rofstad et al,
2002). As discussed below, the biological factors leading to the
radial heterogeneity in the uptake of
99mTc-HSA can be identified
from these studies.
The radial heterogeneity in the uptake of
99mTc-HSA appeared
within minutes after the administration of
99mTc-HSA in both A-07
and R-18 tumours. The blood perfusion in these tumours showed a
radial gradient similar to that in the uptake of
99mTc-HSA. These
two observations together strongly suggest that intratumour
heterogeneity in the supply of
99mTc-HSA through the micro-
vasculature contributed significantly to the initiation of the radial
gradients in
99mTc-HSA uptake.
We have reported previously that our melanoma lines show an
intertumour heterogeneity in the uptake of albumin that is
governed primarily by intertumour differences in extracellular
volume fraction (Graff et al, 2000). However, intratumour
heterogeneity in extracellular volume fraction probably did not
contribute significantly to the radial gradients in
99mTc-HSA
uptake, since neither A-07 nor R-18 tumours showed strong radial
gradients in extracellular volume fraction.
Quantitative studies of the permeability of the microvascular
wall of A-07 and R-18 tumours to Gd-labelled HSA have been
reported elsewhere (Bjrnæs and Rofstad, 2001). The effective
microvascular permeability constant was found to be extremely
high, suggesting that the uptake of HSA in these tumours
is not inhibited significantly by the microvascular wall. However,
intratumour heterogeneity in the effective microvascular
permeability constant was detected, but this heterogeneity
was random. Consequently, intratumour heterogeneity in the
permeability of the microvascular wall probably did not contri-
bute significantly to the radial gradients in
99mTc-HSA uptake
measured here.
Measurements of the radial heterogeneity in interstitial fluid
pressure (IFP) in A-07 tumours have been reported recently
(Rofstad et al, 2002). These measurements showed that the IFP
increased with increasing distance into the tumours until a plateau
was reached at a depth of 0.75mm, that is, the tumours showed a
steep IFP gradient in the periphery and relatively uniform IFP
values at depths beyond 0.75mm. A depth of 0.75mm corresponds
to a normalised radius 40.8 in the tumours used here, implying
that the radial gradients in
99mTc-HSA uptake did not correspond
to the radial gradients in IFP (Rofstad et al, 2002). One possible
explanation is that convection may not be the most important
transport mechanism for
99mTc-HSA (Perl, 1975). Another possible
explanation is that
99mTc-HSA delivered in the tumour periphery
was transported out of the tissue and into the surrounding skin
because of the steep IFP gradient in the tumour periphery. In any
case, the radial gradients in
99mTc-HSA uptake seen here were not
primarily a consequence of radial gradients in IFP.
The radial gradients in the uptake of
99mTc-HSA seen shortly
after the administration of
99mTc-HSA was maintained for at least
180min, that is, until maximum global uptake was reached. This
observation shows that the interstitial transport of
99mTc-HSA
from peripheral tumour regions with high blood perfusion to
central tumour regions with low blood perfusion was inefficient. A
dense and well-organised extracellular matrix may have prevented
efficient transport by diffusion (Hobbs et al, 1998; Krol et al, 1999),
whereas convection may have caused transport from the centre to
the periphery of the tumours, that is, in the opposite direction
(Jain and Baxter, 1988).
Consequently, the studies discussed here collectively suggest
that the tumour microvasculature and the tumour interstitium
represented significant transport barriers for
99mTc-HSA in our
melanoma xenografts, causing radial gradients in the uptake of
99mTc-HSA in non-necrotic tissue. The gradients were initiated
primarily because of radial heterogeneity in the supply of
99mTc-
HSA through the microvasculature. This radial heterogeneity was
maintained at least until maximum global uptake was attained,
mainly because of the presence of significant transport barriers in
the tumour interstitium preventing equalisation of the initial
heterogeneity with time.
The random component of the intratumour heterogeneity in
the uptake of
99mTc-HSA was most likely also caused by the
same transport barriers, that is, heterogeneous supply through
the tumour microvasculature and inadequate transport through
the tumour interstitium. This conclusion follows from the
observations that spots with high
99mTc-HSA uptake colocalised
with spots with high vascular density and regions without
significant
99mTc-HSA uptake colocalised with necrotic regions,
that is, regions at long distances from functional vessels.
If our melanoma xenografts are representative models of cancer
in humans, the study reported here suggests that strategies for
improving the delivery of macromolecular therapeutic agents to
tumours should focus on increasing the tumour blood perfusion
and improving the diffusion conditions in the tumour interstitium.
The increased perfusion may lead to an enhancement of the total
macromolecule uptake and improved diffusion conditions may
lead to a more homogeneous macromolecule distribution in the
tumour tissue.
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